Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × ontuxizumab × Clear all

NCT01507545 2022-05-06

Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)

Phase 2 Terminated

154 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms